In the words of one of USAMMA's contract engineers, Eric Abbott, the supportability analysis "examined how easy the units would be to maintain in the field, availability and expedient delivery of spare parts, availability and source of technical support ..., and stability of the manufacturer...." Although both products passed environmental and operational tests, USAMMA's source selection board chose the one system (see photos above) that met both clinical (or operational) and supportability requirements.
However, USAMMA product teams include engineers, users (USAMMA's clinicians), logisticians, and maintainers who work side by side on a daily basis.
Only through USAMMA's dual-path process can the military clinician assist or lead the selection of a product one year and use that product in the field the very next year to save a life.
Along with reducing unit-owned equipment, USAMMA's concept included improving the generating force's training base locations and centrally managed medical equipping programs.
This study served as the catalyst for the funding that allowed USAMMA, in concert with OTSG, to program some of USAMMA's MMRP initiative into the equipping POMs for fiscal years 2010 to 2015 and 2012 to 2017.
As a bridging strategy to equip the third MMRP tenet, the Army provided approximately $30 million for equipment and overhead costs to modernize four CSHs under OTSG's and USAMMA's control to support U.S.
USAMMA's recommendation on reducing unit-assigned equipment included reexamining what was at home station and what belonged to the unit but was stored at Sierra Army Depot in the FORSCOM Hospital Optimization Standardization Program (HOSP).
In fact, the commander of the 18th Medical Command (MEDCOM) and the 121st CSH in Korea requested that USAMMA maintain its CSH based on USAMMA's success with similar units within the APS program located at Camp Carroll, Korea.